Instituto Nacional de Salud Pública, Cuernavaca, Morelos, México.
Programa Universitario de Investigación en Salud, Universidad Nacional Autónoma de México Ciudad Universitaria, Ciudad de México, México.
BMC Public Health. 2022 Oct 4;22(1):1853. doi: 10.1186/s12889-022-14225-2.
Vaccination against COVID-19 is a primary tool for controlling the pandemic. However, the spread of vaccine hesitancy constitutes a significant threat to reverse progress in preventing the disease. Studies conducted in Mexico have revealed that vaccination intention in Mexico among the general population ranges from 62 to 82%.
To know the prevalence of COVID-19 vaccine hesitancy and associated factors among academics, students, and administrative personnel of a public university in Mexico City.
We administered an online survey investigating sociodemographic aspects, knowledge, attitudes, practices, and acceptance/hesitancy regarding the COVID-19 vaccine. Using generalized linear Poisson models, we analyzed factors associated with vaccine hesitancy, defined as not intending to be vaccinated within the following six months or refusing vaccination.
During May and June 2021, we studied 840 people, prevalence of vaccine hesitancy was 6%. Hesitancy was significantly associated with fear of adverse effects, distrust of physician's recommendations, lack of knowledge regarding handwashing, age younger than 40 years, refusal to use face masks, and not having received influenza vaccination during the two previous seasons.
Vaccine hesitancy in this population is low. Furthermore, our results allowed us the identification of characteristics that can improve vaccine promotion.
接种 COVID-19 疫苗是控制大流行的主要手段。然而，疫苗犹豫的传播对逆转预防疾病的进展构成了重大威胁。在墨西哥进行的研究表明，墨西哥普通人群的疫苗接种意愿在 62%至 82%之间。
了解墨西哥城一所公立大学的学者、学生和行政人员对 COVID-19 疫苗的犹豫率及其相关因素。
我们进行了一项在线调查，调查了社会人口统计学方面、知识、态度、实践以及对 COVID-19 疫苗的接受/犹豫情况。使用广义线性泊松模型，我们分析了与疫苗犹豫相关的因素，将其定义为在接下来的六个月内不打算接种疫苗或拒绝接种疫苗。
在 2021 年 5 月和 6 月期间，我们研究了 840 人，疫苗犹豫率为 6%。犹豫与对不良反应的恐惧、对医生建议的不信任、对手部卫生知识的缺乏、年龄小于 40 岁、拒绝使用口罩以及在前两个季节未接种流感疫苗显著相关。
该人群的疫苗犹豫率较低。此外，我们的结果还确定了可以改善疫苗推广的特征。
